Not logged inImmunogenicity and safety of a recombinant COVID-19 vaccine (ZF2001) as heterologous booster after priming with inactivated vaccine in healthy children and adolescents aged 3-17 years: an open-labeled, single-arm clinical trial
Huang, Tao; Hu, Qianqian; Zhou, Xiang; Yang, Huaiyu; Xia, Wei; Cao, Feng; Deng, Minglu; Teng, Xiaoxue; Ding, Fan; Zhong, Zaixin; Gao, Lidong; Sun, Jiufeng; Gong, Lihui .png)
Share.png)
SaveSafety and immunogenicity of a protein subunit COVID-19 vaccine (ZF2001) in healthy children and adolescents aged 3-17years in China: a randomised, double-blind, placebo- controlled, phase 1trial and an open-label, non-randomised, non-inferiority, phase 2 trialGao, Lidong; Li, Yan; He, Peng; Chen, Zhen; Yang, Huaiyu; Li, Fangjun; Zhang, Siyuan; Wang, Danni; Wang, Guangyan; Yang, Shilong; Gong, Lihui; Ding, Fan; Ling, Mengyu; Wang, Xilu; Ci, Leilei; Dai, Lianpan; Gao, George Fu; Huang, Tao; Hu, Zhongyu; Ying, Zhifang; Sun, Jiufeng; Zuo, Xiaohu Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
